top of page
![Boston_H_color[33632]_edited.png](https://static.wixstatic.com/media/e60c5c_0b72738a80554196840094a8e387c5ed~mv2.png/v1/fill/w_338,h_77,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/Boston_H_color%5B33632%5D_edited.png)
OVERVIEW OF IMMUNE-RELATED ADVERSE EVENTS CAUSED BY IMMUNE CHECKPOINT INHIBITION
Wed, Apr 22
|Webinar - Meeting ID 200422-BMS-54768
Registration is Closed
See other events
Time & Location
Apr 22, 2020, 6:00 PM
Webinar - Meeting ID 200422-BMS-54768
Guests
About The Event
You are cordially invited by your Bristol-Myers Squibb representative to attend a presentation that will focus on:
OVERVIEW OF IMMUNE-RELATED ADVERSE EVENTS CAUSED BY IMMUNE CHECKPOINT INHIBITION
Program Information:
You have been cordially invited by
Jeffrey Read
Meeting ID:
200422-BMS-54768
To RSVP, please call 1-866-326-7600 during the hours of 8:30am to 5:00pm EST,
Wednesday, April 22, 2020 6:00 PM - EST
Virtual Attendee 1000 Wyckoff Ave
Mahwah, New Jersey 07430 (201) 560-5635
Program Faculty:
Jay Patel, PharmD, BCOP Immuno-Oncology Clinical Liaison Bristol-Myers Squibb
bottom of page